國立虎尾科技大學 |

Genitourinary Cancers

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Genitourinary Cancers / edited by Siamak Daneshmand, Kevin G. Chan.
其他作者:	Daneshmand, Siamak.
面頁冊數:	VI, 308 p. 39 illus., 38 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Oncology . -
電子資源:	https://doi.org/10.1007/978-3-319-93339-9
ISBN:	9783319933399

Genitourinary Cancers
Genitourinary Cancers [electronic resource] /edited by Siamak Daneshmand, Kevin G. Chan. - 1st ed. 2018. - VI, 308 p. 39 illus., 38 illus. in color.online resource. - Cancer Treatment and Research,1750927-3042 ;. - Cancer Treatment and Research,165.

New Imaging Techniques in Prostate Cancer -- Targeted ablative therapies for prostate cancer -- Prostate cancer markers -- Prognostic value of CTC’s in urologic cancers -- Management of Small Renal Masses -- Advances in the Treatment of Metastatic Renal Cell Carcinoma.-Imaging in urologic cancers -- Molecular prognostication in Bladder cancer -- Early cystectomy for high risk non-muscle invasive disease -- Care-coordination pathway after radical cystectomy -- Current role of checkpoint inhibitors in urologic cancers -- ) The Cancer Genome Atlas Project -- Prognostic models in germ cell tumors -- Modern management of testicular cancer.

This book addresses the most pressing current questions in the management of urologic malignancies. The rapid advances in imaging and molecular markers are placed into a clinical context, with explanation of their effects on prognosis and treatment planning. Similarly, progress in immunotherapy is carefully examined, focusing in particular on the role of immune checkpoint inhibitors in both early- and late-stage urologic malignancies. Looking beyond the improvements in minimally invasive techniques for urologic cancers, the impacts of care coordination pathways and enhanced recovery after surgery protocols are reviewed. Readers will also find enlightening discussion of the decision algorithm for the treatment of early-stage, high-grade bladder cancer, taking into account evidence on the most advanced treatment options and the circumstances in which surgery may need to be expedited. The penultimate chapter discusses the Cancer Genome Atlas project for bladder cancer, and the book closes by considering contemporary medical and surgical management of testicular cancer.

ISBN: 9783319933399

Standard No.: 10.1007/978-3-319-93339-9doiSubjects--Topical Terms:

1253469
Oncology .

LC Class. No.: RC254-282

Dewey Class. No.: 616.994

Genitourinary Cancers
LDR:03113nam a22004095i 4500 001 988499
003 DE-He213
005 20200630010125.0
007 cr nn 008mamaa
008 201225s2018 gw | s |||| 0|eng d
020 $a 9783319933399 $9 978-3-319-93339-9
024 7 $a 10.1007/978-3-319-93339-9 $2 doi
035 $a 978-3-319-93339-9
050 4 $a RC254-282
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994 $2 23
245 1 0 $a Genitourinary Cancers $h [electronic resource] / $c edited by Siamak Daneshmand, Kevin G. Chan.
250 $a 1st ed. 2018.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a VI, 308 p. 39 illus., 38 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Cancer Treatment and Research, $x 0927-3042 ; $v 175
505 0 $a New Imaging Techniques in Prostate Cancer -- Targeted ablative therapies for prostate cancer -- Prostate cancer markers -- Prognostic value of CTC’s in urologic cancers -- Management of Small Renal Masses -- Advances in the Treatment of Metastatic Renal Cell Carcinoma.-Imaging in urologic cancers -- Molecular prognostication in Bladder cancer -- Early cystectomy for high risk non-muscle invasive disease -- Care-coordination pathway after radical cystectomy -- Current role of checkpoint inhibitors in urologic cancers -- ) The Cancer Genome Atlas Project -- Prognostic models in germ cell tumors -- Modern management of testicular cancer.
520 $a This book addresses the most pressing current questions in the management of urologic malignancies. The rapid advances in imaging and molecular markers are placed into a clinical context, with explanation of their effects on prognosis and treatment planning. Similarly, progress in immunotherapy is carefully examined, focusing in particular on the role of immune checkpoint inhibitors in both early- and late-stage urologic malignancies. Looking beyond the improvements in minimally invasive techniques for urologic cancers, the impacts of care coordination pathways and enhanced recovery after surgery protocols are reviewed. Readers will also find enlightening discussion of the decision algorithm for the treatment of early-stage, high-grade bladder cancer, taking into account evidence on the most advanced treatment options and the circumstances in which surgery may need to be expedited. The penultimate chapter discusses the Cancer Genome Atlas project for bladder cancer, and the book closes by considering contemporary medical and surgical management of testicular cancer.
650 0 $a Oncology . $3 1253469
650 0 $a Urology. $3 645258
650 1 4 $a Oncology. $3 593951
700 1 $a Daneshmand, Siamak. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1141801
700 1 $a Chan, Kevin G. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1208822
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319933382
776 0 8 $i Printed edition: $z 9783319933405
776 0 8 $i Printed edition: $z 9783030066420
830 0 $a Cancer Treatment and Research, $x 0927-3042 ; $v 165 $3 1254896
856 4 0 $u https://doi.org/10.1007/978-3-319-93339-9
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)